The basolateral nucleus of the amygdala (BLA) is critical to the pathophysiology of anxiety-driven alcohol drinking and relapse. The endogenous cannabinoid/type 1 cannabinoid receptor (eCB/CB 1 ) system curbs BLA-driven anxiety and stress responses via a retrograde negative feedback system that inhibits neurotransmitter release, and BLA CB 1 activation reduces GABA release and drives anxiogenesis. Additionally, decreased amygdala CB 1 is observed in abstinent alcoholic patients and ethanol withdrawn rats. Here, we investigated the potential disruption of eCB/CB 1 signaling on GABAergic transmission in BLA pyramidal neurons of rats exposed to 2-3 weeks intermittent ethanol. In the naïve rat BLA, the CB 1 agonist WIN 55,212-2 (WIN) decreased GABA release, and this effect was prevented by the CB 1 antagonist AM251. AM251 alone increased GABA release via a mechanism requiring postsynaptic calcium-dependent activity. This retrograde tonic eCB/CB 1 signaling was diminished in chronic ethanol exposed rats, suggesting a functional impairment of the eCB/CB 1 system. In contrast, acute ethanol increased GABAergic transmission similarly in naïve and chronic ethanol exposed rats, via both presynaptic and postsynaptic mechanisms. Notably, CB 1 activation impaired ethanol's facilitation of GABAergic transmission across both groups, but the AM251-induced and ethanolinduced facilitation of GABA release was additive, suggesting independent presynaptic sites of action. Collectively, the present findings highlight a critical CB 1 influence on BLA GABAergic transmission that is dysregulated by chronic ethanol exposure and, thus, may contribute to the alcohol-dependent state.
INTRODUCTION
The basolateral amygdala (BLA) is critical to the pathophysiology of stress, anxiety disorders and addiction (Quirk & Gehlert 2003; Azad et al. 2004; Stamatakis et al. 2014) , and dysregulation of its aversive emotional learning processes is implicated in several alcohol drinking-related behaviors, such as cue-induced alcohol seeking (Sciascia et al. 2015) and reinstatement (Sinclair et al. 2012) , and withdrawal-associated anxiety-like behaviors (Lack et al. 2007) . The BLA receives highly processed sensory input from the hippocampus, medial prefrontal cortex, thalamus and ventral tegmental area and assigns a negative emotional value to salient events (Stamatakis et al. 2014) . The majority of BLA neurons are glutamatergic pyramidal cells (90-95% of BLA neurons), but local GABAergic interneurons (5-10%) play a critical role in regulating overall BLA activity because of their robust inhibition of pyramidal neurons. The BLA transmits this information to several addictionrelated downstream regions, including the bed nucleus of the stria terminalis, central nucleus of the amygdala (CeA), hippocampus, medial prefrontal cortex and nucleus accumbens (NAc) (Azad et al. 2004; Stamatakis et al. 2014) . Previous work has shown that acute alcohol increases GABA release onto BLA pyramidal neurons (Zhu & Lovinger 2005; Silberman et al. 2008) , thereby limiting excitatory output to downstream effector regions (Perra et al. 2008) , and that chronic ethanol and withdrawal alter BLA GABAergic transmission (McCool et al. 2003; Diaz et al. 2011b) .
Within the BLA, the endogenous cannabinoid/type 1 cannabinoid receptor (eCB/CB 1 ) system plays a wellestablished role in gating stress and anxiety responses by modulating GABA and glutamate neurotransmission (Hill et al. 2010; Serrano & Parsons 2011; Morena et al. 2015) . Specifically, eCBs are released 'on demand' from postsynaptic terminals and act retrogradely at presynaptic CB 1 receptors to decrease neurotransmitter release (Hill et al. 2010; Morena et al. 2015) . CB 1 is expressed widely throughout the brain; in the BLA, it is highly expressed in cholecystokinin-positive GABAergic interneurons (Katona et al. 2001; Yoshida et al. 2011) and at lower levels in glutamatergic pyramidal cells (Yoshida et al. 2011) . Previous work has demonstrated that CB 1 activity decreases BLA GABAergic transmission (Katona et al. 2001; Marsicano et al. 2002; Azad et al. 2004; Zhu & Lovinger 2005) , which can affect emotional processing (Hill et al. 2010; Tan et al. 2014) .
Several studies have linked human allelic variants of the gene encoding CB 1 (CNR1) with an altered patient susceptibility to alcohol dependence, although some of these data are conflicting (Schmidt et al. 2002; Preuss et al. 2003; van den Wildenberg et al. 2007; Marcos et al. 2012) . Furthermore, alterations of the eCB/CB 1 system have been observed in the amygdala of alcoholic patients; CB 1 receptor availability decreased in the amygdala of heavy drinkers with 2-4 weeks of abstinence (Hirvonen et al. 2013; Ceccarini et al. 2014 ) but increased after 4 weeks of abstinence (Neumeister et al. 2012) . Similarly, chronic ethanol exposed rats had reduced amygdala CB 1 gene expression after 6 hours of withdrawal (Serrano et al. 2012) . No studies to date have examined the functional effects of chronic ethanol on BLA eCB/CB 1 signaling, but in the CeA, we recently reported that 2-3-week intermittent ethanol significantly reduced eCB/CB 1 influence on basal GABA release (Varodayan et al. 2015) . Additionally, CB 1 activation blocked ethanol's facilitation of GABA release in the CeA of naive and chronic ethanol exposed rats, even though ethanol and a CB 1 antagonist acted independently to increase GABA release (Roberto et al. 2010; Varodayan et al. 2015) . Given the substantial evidence that alcohol alters BLA CB 1 expression and function, here, we investigated the interaction of the eCB/CB 1 system with the effects of acute ethanol on GABAergic transmission, and its dysregulation by chronic ethanol exposure.
MATERIALS AND METHODS
All procedures were approved by The Scripps Research Institutional Animal Care and Use Committee and were consistent with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Slice preparation
We prepared slices from 78 adult male Sprague Dawley rats (250-350 g) (Roberto et al. 2004; Varodayan et al. 2015) . Rats were anesthetized with 3-5% isoflurane, decapitated, and the brains placed in ice-cold highsucrose solution (pH 7.3-7.4 ; in millimolar): sucrose 206; KCl 2.5; CaCl 2 0.5; MgCl 2 7; NaH 2 PO 4 1.2; NaHCO 3 26; glucose 5; HEPES 5. 300-μm coronal brain slices containing the BLA, were cut on a vibrating microtome (Leica VT1000S, Leica Microsystems, Buffalo Grove, IL, USA). Slices were incubated (30 minutes at 35-37°C, 30 minutes at room temperature) in oxygenated (95% O 2 /5% CO 2 ) artificial cerebrospinal fluid (aCSF; in millimolar): NaCl 130; KCl 3.5; CaCl 2 2; NaH 2 PO 4 1.25; MgSO 4 1.5; NaHCO 3 24; glucose 10. For each experiment, an individual slice was placed in a chamber on an upright microscope stage (Olympus BX50WI, Tokyo, Japan) and superfused at 2-5 ml/minute with oxygenated aCSF.
Electrophysiological recording
Basolateral amygdala pyramidal neurons were visualized using infrared differential interference contrast (IR-DIC) optics, a CCD camera (EXi Aqua and ROLERA-XR, QImaging, Surrey, BC, Canada) and a w60 or w40 water immersion objective (Olympus). Recordings were performed in gap-free acquisition mode (sampling rate/signal of 10 kHz) and low-pass filtered at 10 kHz, using the Multiclamp 700B amplifier, Digidata 1440A and pClamp 10 software (Molecular Devices, Sunnyvale, CA, USA). Patch pipettes (3-6 MΏ; Warner Instruments, Hamden, CT and King Precision, Claremont, CA, USA) were filled with internal solution (in millimolar): KCl 145; EGTA 5; MgCl 2 5; HEPES 10; Na-ATP 2; Na-GTP 0.2. Action potential-dependent spontaneous inhibitory GABA A postsynaptic currents (sIPSCs) were isolated using the glutamate receptor blockers 6,7-dinitroquinoxaline-2,3-dione (DNQX, 20 μM) and DL-2-amino-5-phosphonovalerate (AP-5, 30 μM), and the GABA B receptor antagonist CGP55845A (1 μM), and for action potential-independent miniature IPSCs (mIPSCs) recordings 0.5-μM tetrodotoxin (TTX), was added. All 139 cells were clamped at -60 mV, and experiments with series resistance >15 MΏ or a >20% change, as monitored with a 10 mV pulse, were excluded. The s/mIPSC frequencies, amplitudes and kinetics were analyzed with MiniAnalysis software (Synaptosoft Inc., Fort Lee, NJ, USA). A cell's s/mIPSC characteristics were averaged from a minimum 60 events across 3-5 minutes, and the final s/mIPSC values from at least four animals.
Chronic intermittent ethanol exposure
Chronic intermittent ethanol (CIE) exposed rats (n = 33) were generated using standard cages kept in chambers into which ethanol vapor (14 hours) or air (10 hours) was intermittently injected for 2-3 weeks. Blood alcohol levels (BALs) were determined by twice weekly tail bleedings, with the terminal BAL measured upon sacrifice, and the mean BAL of all CIE animals was 172 ± 22 mg/dl. Naive rats were treated with continuous air (24 hours). For sacrifice, the rats were removed from the ethanol vapor-filled chambers, and slice preparation occurred in ethanol-free solutions. Thus, the brain slices were in acute withdrawal (1-8 hours) during recording.
Drugs
We purchased BAPTA (1,2-Bis(2-Aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid) from Sigma (St. Louis, MO, USA), CGP 55845A, DL-AP5 and DNQX from Tocris (Ellisville, MO, USA), ethanol from Remet (La Mirada, CA, USA) and TTX from Biotium (Hayward, CA, USA). WIN (WIN55,212-2; [(3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo [1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-methanone, monomethanesulfonate) and AM251 (N-(Piperidin-1-yl)-5-(4-iodophenyl)-1-2,4-dichloro phenyl)-4-methyl-1H-pyrazole-3-carboxa-mide) were purchased from Cayman Chemical (Ann Arbor, MI, USA) and dissolved in dimethylsulfoxide (final concentrations of 0.05-0.1%), which had no effect on synaptic responses in control experiments.
Statistics
We used GraphPad Prism 5.0 software (GraphPad Software, San Diego, CA, USA) for statistical analyses. The results were evaluated with cumulative probability analysis, with the Kolmogorov-Smirnov non-parametric two-sample test used to determine significance (Van der Kloot 1991). To control for cell-to-cell variation in baseline IPSC properties, drug effects were normalized to their own neuron's baseline (presented as control) prior to group analyses. We used t-test analyses for individual means comparisons. Two-way ANOVAs were used to assess treatment (naïve and CIE) and drug interactions (ethanol, WIN and AM251) with the Bonferroni test to determine significance. Data are presented as mean ± SEM and n, reported in the text and graphs, represents the cell number of each experimental group.
RESULTS
Chronic ethanol exposure alters GABAergic transmission in the basolateral amygdala via a postsynaptic mechanism Action potential-dependent sIPSCs were recorded from BLA pyramidal neurons of naïve or 2-3-week CIE rats (BAL: 172 ± 22 mg/dl). The mean sIPSC frequencies and amplitudes were comparable. In naïve animals, the sIPSC frequency was 1.63 ± 0.20 Hz, and amplitude was 47.82 ± 2.12 pA (n = 37), whereas in CIE rats, the sIPSC frequency was 1.56 ± 0.23 Hz, and amplitude was 50.81 ± 3.12 pA (n = 34; Fig. 1a-c) . However, with CIE there a significant decrease in sIPSC rise ( # p < 0.05 by unpaired t-test; t(69) = 2.06) and decay times ( # p < 0.05; t(69) = 2.50). In naïve rats, the rise time was 2.85 ± 0.11 ms, and decay time was 10.19 ± 1.00, while in CIE rats, the rise time was 2.54 ± 0.09 ms, and decay time was 7.10 ± 0.70 ms ( Fig. 1a and d) .
Action potential-independent mIPSCs, recorded in TTX, were similar across groups. Naïve rats had a mIPSC frequency of 1.62 ± 0.28 Hz, amplitude of 44.67 ± 1.78 pA, rise time of 2.56 ± 0.09 ms and decay time of 7.87 ± 0.83 ms (n = 29), while CIE rats had a mIPSC frequency of 1.51 ± 0.28 Hz, amplitude of 39.20 ± 2.10 pA, rise time of 2.64 ± 0.09 ms and decay time of 7.87 ± 0.97 ms (n = 34; Fig. 1e-h ). In these experiments, a change in s/mIPSC frequency reflects presynaptic changes that lead to an altered probability of GABA release, while changes in s/mIPSC, amplitude and kinetics reflect altered postsynaptic receptor sensitivity. Therefore, our data suggests that chronic ethanol exposure alters GABA A receptor subunit composition and/or number in the rat BLA Otis, De Koninck & Mody 1994) .
Acute ethanol increases basolateral amygdala GABAergic transmission in naïve and chronic ethanol exposed rats
We then assessed the effects of acute ethanol (44 mM) on spontaneous GABAergic transmission. In the naïve rat BLA, ethanol increased the sIPSC frequency to 155.1 ± 11.0% of baseline (**p < 0.01 by one-sample t-test; n = 8) and amplitude to 115.1 ± 5.4% (*p < 0.05; Fig. 2a and b) . Similarly, in CIE rats, the sIPSC frequency (135.8 ± 9.7%; **p < 0.01; n = 9) and amplitude (114.4 ± 4.8%; *p < 0.05) were increased by ethanol ( Fig. 2a and b) . Apart from the decreased sIPSC decay time in naïve rats (91.4 ± 2.5%; *p < 0.05; Fig. 2b ), there were no significant effects of ethanol on sIPSC kinetics. Acute ethanol also increased the naïve rat BLA mIPSC frequency to 138.6 ± 9.0% of baseline (**p < 0.01; n = 11) and amplitude to 126.3 ± 10.7% (*p < 0.05; Fig. 2c and d) .
In CIE rats, there was a significant increase in mIPSC frequency (125.9 ± 9.7%; *p < 0.05; n = 11) and a trend towards an increased amplitude (120.7 ± 9.6%; p = 0.058) with acute ethanol ( Fig. 2c and d ). There were no differences in mIPSC kinetics after ethanol. Thus, acute ethanol increased BLA GABA transmission, via both presynaptic and postsynaptic mechanisms, in naïve and chronic ethanol exposed rats.
Type 1 cannabinoid receptor activation decreases basolateral amygdala GABA release and chronic ethanol exposure dampens this effect
To investigate the influence of the eCB/CB 1 system on BLA GABA transmission, we used the cannabinoid receptor agonist WIN55,212-2 (WIN; 2 μM) (Roberto et al. 2010; Varodayan et al. 2015) . WIN significantly decreased sIPSC (d) Acute EtOH increased mIPSC frequencies in naive and CIE rats and increased the mIPSC amplitude in naive rats (*p < 0.05; **p < 0.01). EtOH did not alter the mIPSC kinetics in either group frequencies to 62.1 ± 4.6% of baseline (***p < 0.001 by one-sample t-test; n = 15) in the BLA of naïve rats and 79.0 ± 6.0% in CIE rats (**p < 0.01; n = 13; Fig. 3a and b). Notably, chronic ethanol exposure significantly reduced the magnitude of the WIN effect compared with naïve rats ( # p < 0.05 by unpaired t-test; t(216) = 2.29). WIN had no effects on sIPSC amplitudes and kinetics (Fig. 3b) . Similar to the sIPSCs, WIN decreased BLA mIPSC frequencies to 59.5 ± 7.0% of baseline in naïve rats (***p < 0.001 by one-sample t-test; n = 8) and 83.1 ± 7.1% in CIE rats (*p < 0.05; n = 15), although the WIN effect was significantly diminished in CIE versus naïve rats ( # p < 0.05 by unpaired t-test; t(21) = 2.13; Fig. 3c and d ). There were no WIN-induced effects on mIPSC amplitudes and kinetics (Fig. 3d) . Collectively, these data indicate that WIN decreased GABA release, and the magnitude of this effect is dampened by chronic ethanol exposure.
To verify that these WIN effects were mediated by CB 1 , we repeated these experiments after 15 minutes pretreatment with the CB 1 antagonist AM251 (2 μM; see Fig. 5 . for the per se effects of AM251). In naive rat BLA neurons, WIN alone decreased the sIPSC frequency to 62.1 ± 4.6% of baseline, and AM251 pretreatment prevented this WIN-induced effect (97.7 ± 1.6%; ### p < 0.001 by unpaired t-test; t(20) = 5.22; Fig. 3e) . Similarly, the WIN-induced effect on naïve rat BLA mIPSC frequency (59.5 ± 7.0% of baseline) was lost with AM251 pretreatment (98.7 ± 6.7%; ## p < 0.01; t(12) = 3.93; Fig. 3f) . The s/mIPSC amplitudes were unaffected by drug treatment across all groups ( Fig. 3e and f) . Thus, the actions of WIN to decrease GABA release in the BLA occur via CB 1 localized on the presynaptic terminal.
Type 1 cannabinoid receptor activation impairs ethanol facilitation of GABAergic transmission in the basolateral amygdala
To investigate the interaction of CB 1 activation and ethanol in the BLA of naïve and CIE rats, we first applied WIN and then co-applied ethanol in the continued presence of WIN. We found a significant main effect of acute ethanol (in the presence of WIN) on sIPSC frequency (p < 0.01 by two-way repeated measures (RM) ANOVA; F(1, 18) = 12.38), indicating that ethanol increases BLA GABA release after CB 1 activation. Specifically, in naïve rats, the sIPSC frequency was reduced by WIN to 68.1 ± 4.6% of baseline and increased by subsequent ethanol co-application to 84.7 ± 8.0% of baseline (n = 10; Fig. 4a and b). Similarly, in CIE rats, the sIPSC frequency was changed by WIN to 74.2 ± 6.1% of baseline and by ethanol co-application to 81.1 ± 8.2% of baseline (n = 10; Fig. 4a and b) . Although the sIPSC amplitudes were unchanged by CB 1 activation, WIN blocked their increase by ethanol (Fig. 4c) . We next assessed whether CB 1 activation altered ethanol's effect on sIPSC frequency versus ethanol alone (from Fig. 2b ) in naïve and CIE rats. There was a significant main effect of WIN (^^p < 0.01 by twoway ANOVA; F(1, 32) = 10.94; see summary in Fig. 7a ), indicating that the magnitude of the ethanol effect on sIPSC frequency was impaired by CB 1 activation across both animal groups. Similar to the sIPSCs, we found a significant main effect of acute ethanol (in the presence of WIN) on mIPSC frequency across both naïve and CIE rats (p < 0.05 by two-way RM ANOVA; F(1, 13) = 7.55). Specifically, in naïve rats, ethanol co-application increased the WIN effect on mIPSC frequency from 61.6 ± 7.8% to 78.1 ± 9.9% of baseline (n = 7; Fig. 4d and e) . Additionally, in CIE rats, the mIPSC frequency was changed by WIN to 88.8 ± 10.6% of baseline and by subsequent ethanol co-application to 104.9 ± 14.2% of baseline (n = 8; Fig. 4d and e). WIN also blocked the ethanol-induced increase of BLA mIPSC amplitude in naïve rats (Fig. 4f) . Further analysis of the effects of ethanol alone (from Fig. 2d ) versus ethanol plus WIN on mIPSC frequency identified no significant main effects of WIN and CIE (p > 0.05 by two-way ANOVA; see summary in Fig. 7b ). Thus, CB 1 activation impaired ethanol's facilitation of GABA transmission in the BLA of both naïve and chronic ethanol exposed rats.
Tonic endogenous cannabinoid/type 1 cannabinoid receptor signaling regulates basolateral amygdala GABA release, an effect dampened by chronic ethanol exposure To further investigate the role of endogenously formed eCBs in basal GABAergic transmission, we assessed the effects of the CB 1 antagonist AM251. Superfusion of AM251 (2 μM) significantly increased the BLA sIPSC frequency to 143.2 ± 7.4% of baseline (**p < 0.01 by onesample t-test; n = 7) in naïve rats and to 115.6 ± 4.6% in CIE rats (**p < 0.01; n = 12; Fig. 5a and b) . However, chronic ethanol significantly reduced the magnitude of the AM251 effect compared with naïve rats ( ## p < 0.01 by unpaired t-test; t(17) = 3.37). AM251 did not alter the sIPSC amplitudes or kinetics in either group (Fig. 5b) . Similarly, AM251 increased the BLA mIPSC frequency to 139.9 ± 10.0% of baseline (**p < 0.01 by one-sample t-test; n = 10) in naïve rats, and to 115.7 ± 6.7% in CIE rats (*p < 0.05; n = 8; Fig. 5c and d) , and the magnitude of the AM251 effect was significantly decreased in CIE versus naïve rats ( # p < 0.05 by unpaired t-test; t(16) = 2.14). There were no AM251-induced effects on mIPSC amplitudes and kinetics (Fig. 5d) . We conclude that eCB/CB 1 signaling tonically regulates inhibitory transmission in the BLA by decreasing basal GABA release and chronic ethanol exposure dampens this influence.
To determine whether this tonic regulation resulted from constitutive CB 1 activity (Turu & Hunyady 2010) , as opposed to eCB release, we buffered our recording cells by including 10-mM BAPTA in the internal solution to prevent postsynaptic calcium-dependent formation and/or mobilization of eCBs (Hentges, Low & Williams 2005; Neu, Foldy & Soltesz 2007; Roberto et al. 2010; Varodayan et al. 2015) . There were significantly higher s/mIPSC baseline frequencies in the naive rat neurons loaded with BAPTA versus normal internal solution; BAPTA increased the sIPSC frequency from 1.63 ± 0.20 Hz (n = 37) to 4.38 ± 0.53 Hz (n = 6; p < 0.001 by unpaired t-test; t(41) = 5.13) and the mIPSC frequency from 1.62 ± 0.28 Hz (n = 29) to 4.50 ± 0.27 Hz (n = 3; p < 0.01; t(30) = 3.24). Additionally, the AM251 effects on sIPSCs were lost in the BAPTA-loaded neurons as the sIPSC frequency decreased from 143.2 ± 7.4% of baseline under normal conditions to 99.1 ± 4.3% in BAPTA-loaded cells (n = 6; ### p < 0.001 by unpaired t-test; t(11) = 4.96; Fig. 5e ). Similarly, the AM251 effect on mIPSCs under normal conditions (139.9 ± 10.0% of baseline) was lost in BAPTA-loaded neurons (95.8 ± 3.2%; Fig. 5f ). There were no significant differences in s/mIPSC amplitudes ( Fig. 5e and f) . Collectively, these data indicate that local release of eCBs in the BLA act in a retrograde manner on presynaptic CB 1 to regulate GABA release.
Type 1 cannabinoid receptor antagonism does not block the ethanol facilitation of GABA release As AM251 and ethanol both increase GABA release in the BLA of naive and CIE rats, we investigated their interactions by first applying AM251 followed by co-application of ethanol in the continued presence of AM251. We found significant main effects of ethanol (in the presence of AM251; p < 0.001 by two-way RM ANOVA; F(1, 10) = 30.19) and CIE on sIPSC frequency (p < 0.01; F(1, 10) = 11.86), and a significant interaction (p < 0.05; F(1, 10) = 5.58). A post hoc Bonferroni test revealed that the effects of AM251 alone versus ethanol and AM251 co-application are significantly different in naive rats ( ### p < 0.001). Specifically in naive rats, AM251 increased the sIPSC frequency to 143.8 ± 10.6% of baseline, and co-application of ethanol further increased it to 213.7 ± 20.6% of baseline (n = 5; Fig. 6a and b). In CIE rats, the BLA sIPSC frequency was increased to 118.9 ± 6.2% of baseline by AM251 and to 146.8 ± 7.9% of baseline by ethanol and AM251 (n = 7; Fig. 6a and b). AM251 had no significant effects on sIPSC amplitudes in either animal group but blocked their ethanol-induced enhancement (Fig. 6c) . We next examined the effect of ethanol alone versus ethanol plus AM251, and there were no significant main effects of AM251 or CIE (p > 0.05 by two-way ANOVA; see summary in Fig. 7a ), indicating that CB 1 antagonism and ethanol act independently to increase BLA GABA release. Similar additive effects of AM251 and ethanol were observed on action potential-independent GABA release, and across both naive and CIE rats, there was a significant main effect of ethanol (in the presence of AM251) on mIPSC frequency (p < 0.05 by two-way RM ANOVA; F(1, 9) = 5.81). Specifically, AM251 enhanced the mIPSC frequency to 157.4 ± 20.0% of baseline (n = 6) in naive rats, and co-application of ethanol and AM251 further increased it to 172.3 ± 25.8% of baseline ( Fig. 6d and e) . In CIE rats, the mIPSC frequency was increased by AM251 to 121.8 ± 7.3% of baseline (n = 5) and further increased to 141.7 ± 10.4% of baseline with ethanol co-application (Fig. 6d and e) . AM251 also blocked the ethanol-induced increase of mIPSC amplitude in naive rats (Fig. 6f) . Further analysis of the effects of ethanol alone versus ethanol plus AM251 on mIPSC frequency revealed no significant main effects of AM251 or CIE (p > 0.05 by two-way ANOVA; see summary in Fig. 7a) . Thus, both CB 1 blockade and ethanol increased GABA release in an additive manner, and this AM251-ethanol (EtOH) interaction was not impaired by CIE, suggesting that the two drugs have different sites of action at the presynaptic terminal. In addition, in four naïve BAPTA-loaded neurons exposed to AM251 (Fig. 5e) , we subsequently tested the effects of acute ethanol. We found that in the continued presence of AM251 and postsynaptic calcium buffering, co-application of ethanol significantly increased the mean sIPSC frequency from 103.7 ± 9.7% to 130.1 ± 3.4% (**p < 0.01 by one-sample t-test; n = 4) and this ethanolinduced effect was significantly higher than AM251 alone ( ## p < 0.01 by unpaired t-test; t(3) = 6.28; Fig. 6g ).
We observed similar results in BLA mIPSCs recorded from three naïve BAPTA-loaded neurons continuously exposed to AM251 (Fig. 5f ). Specifically, ethanol increased the mIPSC frequency from 95.8 ± 3.2% to 135.5 ± 7.4% (*p < 0.05 by one-sample t-test; n = 3), and the effects of AM251 alone versus ethanol plus AM251 were significantly different ( # p < 0.05 by unpaired t-test; t(2) = 6.69; Fig. 6h ). There were no changes in s/mIPSC amplitudes ( Fig. 6g and h ). These results further support our findings that the eCB/CB 1 system and ethanol have additive effects on BLA GABA release.
DISCUSSION
The eCB/CB 1 regulation of BLA neurotransmission appears critical in the neural basis of addiction because of the region's prominent role in aversive emotional processing, learning and memory (Stamatakis et al. 2014; Tan et al. 2014) . Here, we report that eCB/CB 1 retrograde signaling tonically inhibits GABA release onto BLA pyramidal neurons and chronic intermittent ethanol exposure significantly diminishes this eCB/CB 1 influence. Additionally, BLA GABAergic transmission is increased by acute ethanol via both presynaptic and postsynaptic mechanisms. While CB 1 activation impairs ethanol's facilitation of GABAergic transmission, the ethanol presynaptic site of action is likely independent of CB 1 as acute ethanol further increases GABA release in the presence of a CB 1 antagonist (Fig. 7) .
The eCBs, synthesized postsynaptically in response to cellular activity, limit GABA release by binding to presynaptic CB 1 and thereby activating intracellular G i/o -protein pathways to inhibit neurotransmitter release (Hill et al. 2010; Turu & Hunyady 2010; Serrano & Parsons 2011; Morena et al. 2015) . Here, we found that the CB 1 agonist WIN decreased both action potentialdependent and independent GABA release (sIPSCs and mIPSCs) in the BLA of naïve rats, and these effects were prevented by the CB 1 antagonist AM251. AM251 alone increased both types of GABA release via a mechanism requiring postsynaptic calcium-dependent activity (as revealed by BAPTA blockade of the AM251 effect), strengthening our finding of basal eCB tone rather than constitutive CB 1 activity (Turu & Hunyady 2010) . Collectively, these results indicate that endogenous eCB signaling acts exclusively on presynaptic CB 1 to inhibit basal GABA release onto BLA pyramidal neurons. Other groups have consistently observed reduced BLA GABAergic transmission with CB 1 activation (Katona et al. 2001; Marsicano et al. 2002; Azad et al. 2004; Zhu & Lovinger 2005; Talani & Lovinger 2015) . However, studies on basal eCB tone produce more variable results; in young rats CB 1 antagonism had no effect on GABA transmission in BLA slices but increased GABA release in the majority of mechanically-isolated BLA neurons (Zhu & Lovinger 2005; Talani & Lovinger 2015) . Additionally, Perra et al. did not observe basal eCB signaling in the adult rat BLA when performing in vivo extracellular single-unit electrophysiology (Perra et al. 2008) . Similar to the present study, we have reported inhibitory effects of eCB tone on GABA release in the medial subdivision of the CeA (Roberto et al. 2010; Varodayan et al. 2015) , but this effect is region-specific as CB 1 activation did not significantly affect evoked GABAergic transmission in the lateral CeA (Ramikie et al. 2014) .
In contrast to the effects of CB 1 activation, acute ethanol increased GABA release and altered postsynaptic GABA A receptor function in the BLA of naïve and CIE rats. Previous studies have reported a similar ethanol facilitation of BLA GABAergic transmission in naïve neurons (Zhu & Lovinger 2005; Silberman et al. 2008; Talani & Lovinger 2015) , and ethanol's pre-and postsynaptic actions have been attributed to distinct BLA interneuron populations (local versus paracapsular interneuron synapses with BLA pyramidal neurons) (Silberman et al. 2008) . Additionally, we found that the CB 1 agonist WIN impaired ethanol's effects on GABAergic transmission in naïve and CIE rats, while AM251 only altered its actions at the postsynaptic terminal (Fig. 7) . Interestingly, Talani et al. (2015) reported that WIN blocked ethanol-induced BLA GABA release in young and adult rats but only assessed the interaction between CB 1 antagonism and ethanol in young animals, reporting that a higher ethanol concentration (150 mM versus 80 mM) was required to increase GABA release in the presence of the CB 1 antagonist. In contrast, we observed that even though the CB 1 agonist dampens ethanol's actions, ethanol's facilitation of adult rat BLA GABA release does not involve CB 1 . Instead, ethanol and WIN likely have independent presynaptic sites of action yet share common downstream signaling elements. It is tempting to speculate that the bidirectional effects of CB 1 activation and ethanol on GABA release may derive from their opposing regulation of adenlylyl cyclase (AC). Specifically, eCB/CB 1 -binding activates G i/o proteins that inhibit AC to suppress GABA release (Hill et al. 2010; Turu & Hunyady 2010; Serrano & Parsons 2011; Morena et al. 2015) , while AC is activated by ethanol (Tabakoff et al. 2001; Yoshimura et al. 2006 ) and its activation with forskolin promotes GABA release (Talani & Lovinger 2015) . Additionally, Talani et al. (2015) recently reported that ethanol facilitation of BLA GABA release is blocked by AC inhibition; an effect previously observed in the CeA (Cruz et al. 2011) and cerebellum (Kelm, Criswell & Breese 2008) . Therefore, we hypothesize that the initial actions of ethanol and eCBs may converge on the AC/PKA signaling pathway to antagonistically regulate BLA GABA release.
Chronic ethanol had no effect on baseline GABA release in the BLA but significantly decreased sIPSC kinetics, indicating altered GABA A postsynaptic receptor function compared with naïve animals. Notably, significant changes in the membrane abundance of GABA A receptor subunits (increased α4 and γ, and decreased α1, α2 and δ levels) have been reported in the BLA of rats exposed to ethanol for 4 months, and this subunit composition profile was associated with shortened mIPSC kinetics (Lindemeyer et al. 2014) . However, BLA mIPSC kinetics were modestly increased after 10 days of ethanol exposure of periadolescent rats (Diaz et al. 2011b) . Interestingly, we found that chronic ethanol exposure did not alter acute ethanol's effects on presynaptic and postsynaptic GABA terminals. A similar lack of acute ethanol tolerance with regard to BLA GABA transmission was previously observed in 10-12 day ethanol exposed rats (McCool et al. 2003; Diaz et al. 2011b ) and this effect persisted 24 hours into withdrawal (Diaz et al. 2011b) . Therefore, our 2-3 weeks of ethanol exposure likely alters the GABA A receptor subunit composition of BLA pyramidal neurons in adult male rats, but the acute ethanol sensitivity of these BLA pyramidal synapses is retained. Figure 6 Ethanol still increases basolateral amygdala (BLA) GABA release after type 1 cannabinoid receptor (CB 1 ) antagonism. (a) Representative BLA spontaneous inhibitory postsynaptic currents (sIPSCs) in control conditions and during application of AM251 (2 μM) and AM251 + ethanol (EtOH; 44 mM) from naive (left) and chronic intermittent ethanol (CIE) (right) rats. (b) Ethanol increased spontaneous GABA release after CB 1 antagonism in the BLA of both naïve and CIE rats. Bar graphs plotting the changes in sIPSC frequency induced by AM251 and AM251 + EtOH (*p < 0.05; **p < 0.01 by onesample t-test). A two-way RMA ANOVA revealed significant main effects of ethanol (in AM251; p < 0.001 by two-way RM ANOVA) and CIE (p < 0.01) on sIPSC frequency, and a significant interaction (p < 0.05). Specifically, the effects of AM251 + EtOH on sIPSC frequency were significantly different versus AM251 alone in the naive rat BLA ( Fig. 5e ) and with the subsequent addition of EtOH (**p < 0.01 by one-sample t-test). In naive neurons EtOH increased the sIPSC frequency versus BAPTA/AM251 alone cells ( ## p < 0.01 by unpaired t-test) and had no effect on the sIPSC amplitude. (h) The effect of EtOH on mIPSC frequency in the presence of AM251 and with BAPTA in the recording pipette (same neurons in Fig. 5f ) was significantly different versus baseline (*p < 0.05 by one-sample t-test) and also significantly different versus BAPTA/AM251 alone ( # p < 0.05 by unpaired t-test). There were no significant differences in mIPSC amplitudes
In contrast, the effects of WIN and AM251 on GABA release are greatly diminished in CIE rats, although WIN still dampens ethanol's facilitation of GABAergic transmission. Importantly, these experiments were conducted during the initial hours of withdrawal from 2 to 3 weeks of ethanol exposure (brain slices were maintained in an ethanol-free aCSF), and it is currently unknown how rapidly and in which direction the BLA eCB/CB 1 system responds to early withdrawal. Nevertheless, our observed decrease in BLA CB 1 function in CIE rats likely stems from changes in receptor density; decreased amygdala CB 1 mRNA were observed in rats undergoing 6 hours of withdrawal from 3 weeks of chronic ethanol exposure, although this effect was lost after 24 hours of withdrawal (Serrano et al. 2012) . In these animals, the gene expression of eCB biosynthesis and clearance enzymes was also transiently altered, suggesting that the changes in CB 1 mRNA levels may be compensatory (Serrano et al. 2012) . Fluctuations in amygdala eCB/CB 1 signaling also have been observed in alcoholic patients; CB 1 receptor availability decreased with 2-4 weeks of abstinence (Hirvonen et al. 2013; Ceccarini et al. 2014 ) but increased after 4 weeks of abstinence (Neumeister et al. 2012) . Alternatively, disrupted CB 1 G i/o -protein coupling has been observed after drug exposure (Turu & Hunyady 2010; Serrano & Parsons 2011) , and this mechanism may also contribute to our finding of reduced CB 1 influence. As BLA GABAergic transmission is regulated by an eCB tone in naive rats (discussed above) and chronic ethanol dampens CB 1 influence in the BLA, it is surprising that basal GABA release was unaltered in the BLA of CIE rats. We suspect that the chronic ethanol-induced changes in CB 1 function may be offset by enhanced BLA eCB levels (Serrano et al. 2012) , but dysregulation of other neuromodulatory systems, such as cholecystokinin (Chung & Moore 2007) , dopamine (Diaz et al. 2011a; Chu et al. 2012) , norepinephrine (Miyajima et al. 2010; Silberman, Ariwodola & Weiner 2012) and serotonin (Hofelmann et al. 2013) , may also be involved in reestablishing normal levels of basal GABAergic transmission after 2-3 weeks of intermittent ethanol exposure.
The BLA plays a central role in the pathophysiology of alcohol dependence by promoting anxiety-driven alcohol drinking (Quirk & Gehlert 2003; Stamatakis et al. 2014; Tan et al. 2014) , and in abstinent alcoholic patients, stress/anxiety leads to alcohol cravings and relapse susceptability (Cooney et al. 1997; Fox et al. 2007; Sinha et al. 2009 ). In the rodent BLA, the eCB/CB 1 system regulates local GABAergic release (Katona et al. 2001; Marsicano et al. 2002; Azad et al. 2004; Zhu & Lovinger 2005; Talani & Lovinger 2015) to modulate glutamatergic output to downstream effector regions (Perra et al. 2008) . Therefore, eCB/CB 1 inhibitory control of BLA pyramidal neuron excitability (in addition to the cell's excitatory synaptic inputs and intrinsic excitability) can play a critical role in maintaining appropriate emotional responses (Rau, Ariwodola & Weiner 2015a; Rau et al. 2015b) . While 2-3 weeks of ethanol exposure did not significantly alter baseline inhibitory synaptic inputs onto BLA pyramidal cells, 10 days of ethanol exposure increased BLA glutamatergic transmission (Lack et al. 2007; Lack et al. 2009 ). Critically, we found that eCB/CB 1 signaling in the BLA is functionally dampened after chronic ethanol, presumably reducing its inhibitory control over pyramidal neuron excitability and potentially contributing to the increased overall BLA excitability observed in models of alcohol drinking and dependence (Lack et al. 2007; Sinclair et al. 2012; Sciascia et al. 2015) . Thus, the diminished influence of the eCB/CB 1 system after chronic ethanol exposure has direct Figure 7 Summary of endogenous cannabinoid/type 1 cannabinoid receptor (CB 1 ) and ethanol interactions on GABA release in the basolateral amygdala (BLA). CB 1 activation impairs the ethanol response, but the effects of ethanol and a CB 1 antagonist are additive. (a) Bar graphs plotting sIPSC frequencies of EtOH alone (44 mM; normalized to the pre-ethanol baseline; from Fig. 2B ), EtOH in the presence of WIN (2 μM; normalized to WIN alone) and EtOH in the presence of AM251 (2 μM; normalized to AM251 alone) in naive and CIE rats. WIN-induced activation of CB 1 impairs the effects of EtOH on BLA GABA release (main effect:^^p < 0.01 by two-way ANOVA). In contrast, CB 1 antagonism and ethanol act independently to increase spontaneous GABA release (p > 0.05 two-way ANOVA). (b) Bar graphs plotting mIPSC frequencies of EtOH alone (from Fig. 2d) , EtOH in the presence of WIN, and EtOH in the presence of AM251 in naive and CIE rats. CB 1 agonism and antagonism do not affect EtOH facilitation of action potential-independent GABA transmission (p > 0.05 two-way ANOVA) effects on local inhibitory control that may significantly impact overall BLA excitability, to dysregulate aversive emotional learning processes and promote anxiety-driven drinking associated with alcohol dependence.
